The difference between “selective folinic acid protection” and “folinic acid rescue” in L5178Y cells culture
- 1 August 1977
- journal article
- research article
- Published by Elsevier in European Journal of Cancer (1965)
- Vol. 13 (8), 861-871
- https://doi.org/10.1016/0014-2964(77)90142-6
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Impaired responsiveness to folinic acid protection in methotrexate-resistant L5178Y cellsEuropean Journal of Cancer (1965), 1975
- Methotrexate resistance and uptake of DDMP by L5178Y cells: Selective protection with folinic acidEuropean Journal of Cancer (1965), 1975
- Methodichlorophen as anti-tumor drug.BMJ, 1975
- Recent advances in the chemotherapy of metastatic osteogenic sarcomaCancer, 1972
- Methotrexate toxicity: Correlation with duration of administration, plasma levels, dose and excretion patternEuropean Journal of Cancer (1965), 1972
- Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancerCancer, 1972
- Toxic and therapeutic effects of methotrexate-folinic acid (leucovorin) in advanced cancer and leukemiaWriting committee for the southeastern cancer study groupCancer, 1971
- Treatment of leukemia with large doses of methotrexate and folinic acid: clinical-biochemical correlatesJCI Insight, 1969
- Eradication Of Leukaemic Cells (L1210) by Methotrexate and Methotrexate Plus Citrovorum FactorNature, 1966
- REVERSAL OF AMINOPTERIN AND AMETHOPTERIN TOXICITY BY CITROVORUM FACTORJAMA, 1950